Mark F. Lindsay
CIK: 0001835542
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VVOS
Vivos Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About Lindsay Mark F.
Lindsay Mark F. (SEC CIK 0001835542) files insider reports with the SEC as Director of Vivos Therapeutics, Inc. (VVOS).
Signal8 holds 1 ownership filing by Lindsay Mark F., a Form 4, filed on Oct 26, 2026. Those filings report 1 transaction, the latest on Sep 14, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Lindsay Mark F.'s filings is in LITTLETON, CO.
Recent filings by Lindsay Mark F.
- Sep 14, 2026: Grant or award of VVOS derivative securities (Form 4, code A).
Other insiders filing for Vivos Therapeutics, Inc. (VVOS)
- Krammer Anja B, Director
- Green Ralph Elias, Director
- SOKOLOW LEONARD J, Director
- JOHNSON GREGG C, Director
- Huntsman Ronald Kirk, Chief Executive Officer
- Amman Bradford K., Principal Accounting Officer